Skip to Main Content

Author Details

Shereen Ezzat
University of Toronto
1979
322
66
PMIDPaper TitleJournal TitlePublished Year
36074932Risk of Adverse Cardiovascular Outcomes in Differentiated Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis.Thyroid2023
3770348268 Ga-DOTATATE PET/CT in the Initial Diagnosis of Patients With Clinical, Imaging, and/or Biochemical Suspicion of a Neuroendocrine Tumor.Clin Nucl Med2023
37166678The Driver Role of Pathologists in Endocrine Oncology: What Clinicians Seek in Pathology Reports.Endocr Pathol2023
36701047FLCN-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the Endocrine Manifestations of Birt-Hogg-Dubé Syndrome.Endocr Pathol2023
35294740Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.Endocr Pathol2022
37435449Pituitary carcinoma: reclassification and implications in the NET schema.Endocr Oncol2022
35996156SCP2 variant is associated with alterations in lipid metabolism, brainstem neurodegeneration, and testicular defects.Hum Genomics2022
36358408Endoscopic Treatment of Rathke's Cleft Cysts: The Case for Simple Fenestration.Brain Sci2022
35217229Endoscopic Treatment of Sellar Arachnoid Cysts via a Simple Cyst-Opening Technique: Long-Term Outcomes From a Single Center.World Neurosurg2022
33203535Endoscopic Endonasal Pituitary Surgery For Nonfunctioning Pituitary Adenomas: Long-Term Outcomes and Management of Recurrent Tumors.World Neurosurg2021
33815279Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease.Front Endocrinol (Lausanne)2021
33660164The Pangenomic Classification of Pituitary Neuroendocrine Tumors: Quality Histopathology is Required for Accurate Translational Research.Endocr Pathol2021
34388408Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer.Oral Oncol2021
34067494An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism.J Clin Med2021
34238480Hypothalamic hormone-producing tumors.Handb Clin Neurol2021
33433883Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?Endocr Pathol2021
33047394Prolactin, a potential biomarker for chronic GVHD activity.Eur J Haematol2021
32126932A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.Thyroid2020
31834538Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution.Pituitary2020
33027678Retraction Notice to: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes.Cell Metab2020
32756001Molecular profiling confirms historical immunohistochemistry in acromegaly.Endocr Relat Cancer2020
32560596Response to Miyauchi <i>et al.</i> re: "A Prospective Mixed-Methods Study of Decision Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer".Thyroid2020
28739080Tools for Enhancement and Quality Improvement of Peer Assessment and Clinical Care in Endocrinology and Metabolism.J Clin Densitom2019
31896937A primer on the genetics of medullary thyroid cancer.Curr Oncol2019
31766255The Clinicopathological Spectrum of Acromegaly.J Clin Med2019
31708875The Clinicopathological Spectrum of Parathyroid Carcinoma.Front Endocrinol (Lausanne)2019
31708652Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.Curr Oncol2019
31300997A Systematic Review and Meta-Analysis of the Diagnostic Performance of BRAF V600E Immunohistochemistry in Thyroid Histopathology.Endocr Pathol2019
31207914Treatment Options for Pancreatic Neuroendocrine Tumors.Cancers (Basel)2019
31368132Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.Clin Genet2019
31540509Management of Small Bowel Neuroendocrine Tumors.Cancers (Basel)2019
31396154A Systematic Review and Meta-Analysis of Patient Preferences for Combination Thyroid Hormone Treatment for Hypothyroidism.Front Endocrinol (Lausanne)2019
31592449Co-occurrence of breast cancer and neuroendocrine tumours: New genetic insights beyond Multiple Endocrine Neoplasia syndromes.Endocrinol Diabetes Metab2019
30949895Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis.J Cancer Surviv2019
30706322An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.Endocr Pathol2019
31115855Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk Disease.Ann Surg Oncol2019
31105270A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.Br J Cancer2019
30657362PREDICTIVE MARKERS FOR POSTSURGICAL MEDICAL MANAGEMENT OF ACROMEGALY: A SYSTEMATIC REVIEW AND CONSENSUS TREATMENT GUIDELINE.Endocr Pract2019
30657358ENDOCRINE COMPLICATIONS IN PATIENTS WITH GVHD.Endocr Pract2019
30385121Re: Quality of life and symptom impact of thyroid cancer: A cross-sectional survey of Canadian patients.Surgery2019
30379651Hypothalamic Vasopressin-Producing Tumors: Often Inappropriate Diuresis But Occasionally Cushing Disease.Am J Surg Pathol2019
28919299The retrotransposon gag domain containing protein Rgag4 is an Ikaros target in the pituitary.Mol Cell Endocrinol2018
30191868Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.Int J Radiat Oncol Biol Phys2018
29915428A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.Nat Genet2018
30217041The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations.J Clin Med2018
30215160Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.Endocr Pathol2018
30102832Symptom burden in adults with thyroid cancer.Psychooncology2018
29881291A large and aggressive fibromatosis in the axilla: a rare case report and review of the literature.Onco Targets Ther2018
30061373Retraction for Wei et al., "The Breast Cancer Susceptibility Gene Product Fibroblast Growth Factor Receptor 2 Serves as a Scaffold for Regulation of NF-κB Signaling".Mol Cell Biol2018
30455668Intrathyroidal Parathyroid Carcinoma: An Atypical Thyroid Lesion.Front Endocrinol (Lausanne)2018
  • 1 - 50 of 322

Recommended Authors

Samira M Sadowski
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2012
Number of shared co-authors 3
Sudheer Kumar Gara
National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 1
Jocelyn F Burke
Kirk Kerkorian School of Medicine of University of Nevada
Career Start Year 2002
Number of shared co-authors 0
Naris Nilubol
Center for Cancer Research
Career Start Year 2001
Number of shared co-authors 5
Electron Kebebew
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 4
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 6
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 11
Richard T Kloos
Veracyte Inc.
Career Start Year 1995
Number of shared co-authors 1
Peter Kopp
University of Lausanne
Career Start Year 1993
Number of shared co-authors 0
Charles E Lyons
Massey Cancer Center, Virginia Commonwealth University
Career Start Year 1992
Number of shared co-authors 0
Dhaval Patel
National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 3
Matthew D Ringel
The Ohio State University College of Medicine and Comprehensive Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Mark Gurnell
Wellcome-MRC Institute of Metabolic Science and Addenbrooke's Hospital
Career Start Year 1990
Number of shared co-authors 0
Juha Kononen
Central Finland Hospital Nova
Career Start Year 1990
Number of shared co-authors 0
Thomas J Giordano
University of Michigan ann arbor
Career Start Year 1989
Number of shared co-authors 8
Fred C G J Sweep
Radboud University Medical Centre
Career Start Year 1987
Number of shared co-authors 3
Eric P Smith
University of Cincinnati College of Medicine
Career Start Year 1986
Number of shared co-authors 0
Motoyasu Saji
The Ohio State University School of Medicine
Career Start Year 1985
Number of shared co-authors 0
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 0
Gilbert J Cote
The University of Texas MD Anderson Cancer Center Houston
Career Start Year 1983
Number of shared co-authors 1
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 0
Daniel Picard
Groupe Hospitalier Universitaire Pitie-Salpetriere
Career Start Year 1981
Number of shared co-authors 5
David M Thomas
Garvan Institute of Medical Research
Career Start Year 1980
Number of shared co-authors 5
Clive S Grant
Inova Health System
Career Start Year 1979
Number of shared co-authors 0
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 8
Barbara Jarzab
M. Sklodowska-Curie National Research Institute of Oncology Gliwice Branch
Career Start Year 1976
Number of shared co-authors 1
Robert C Smallridge
Mayo Clinic School of Medicine, Mayo Clinic
Career Start Year 1975
Number of shared co-authors 1
Robert F Gagel
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 7
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 1
Stephen R Plymate
University of Washington
Career Start Year 1973
Number of shared co-authors 4

Collaborators

David P Goldstein
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 30
Wei Liu
The Ontario Cancer Institute, University Health Network, University of Toronto
Co-authored papers 19
Gary Rodin
Princess Margaret Cancer Centre (University Health Network)
Co-authored papers 10
Gelareh Zadeh
University of Toronto
Co-authored papers 8
Rose Hurren
Princess Margaret Cancer Centre
Co-authored papers 5
Aaron D Schimmer
Princess Margaret Cancer Centre
Co-authored papers 5
Raymond H Kim
Cardiac Genome Clinic, The Hospital for Sick Children
Co-authored papers 5
Glenn D Braunstein
Co-authored papers 4
Alessandro Datti
University of Perugia
Co-authored papers 4
Shalender Bhasin
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 3
Nestor F Gonzalez-Cadavid
Cedar-Sinai Medical Center
Co-authored papers 3
Anthony M Joshua
The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney
Co-authored papers 3
Edward R Laws
Co-authored papers 3
Ian E McCutcheon
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 3
Jeffrey L Wrana
Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital
Co-authored papers 3
Craig D Simpson
The Hospital for Sick Children, University Avenue
Co-authored papers 2
Kathleen A Jablonski
Co-authored papers 2
Reza Beheshti Zavareh
The Scripps Research Institute
Co-authored papers 2
Jose C Florez
Co-authored papers 2
Karen K Miller
Co-authored papers 2
Stephen J Marx
National Institutes of Digestive Disease and Kidney, National Institutes of Health
Co-authored papers 2
Kyle Juraschka
The Hospital for Sick Children, University of Toronto
Co-authored papers 2
Markku Laakso
Co-authored papers 2
Maegan Harden
Broad Institute of MIT and Harvard.
Co-authored papers 2
Alena Stančáková
Co-authored papers 2
Marcela Gronda
Princess Margaret Cancer Centre
Co-authored papers 2
Wei Xu
Princess Margaret Cancer Centre
Co-authored papers 2
Arie Perry
University of California san francisco
Co-authored papers 2
Zhengping Zhuang
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Cheryl Ho
University of British Columbia
Co-authored papers 1
Release 1.2